Preferred Name |
Atazanavir Sulfate |
|
Synonyms |
|
|
Definitions |
A sulfate salt form of atazanavir, an aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C28835 |
|
CAS_Registry |
229975-97-7 |
|
CHEBI_ID |
CHEBI:31243 |
|
Chemical_Formula |
C38H52N6O7.H2O4S |
|
code |
C28835 |
|
Contributing_Source |
FDA |
|
definition |
A sulfate salt form of atazanavir, an aza-dipeptide analogue with a bis-aryl substituent on the (hydroxethyl)hydrazine moiety with activity against both wild type and mutant forms of HIV protease. Atazanavir does not elevate serum lipids, a common problem with other protease inhibitors. |
|
FDA_UNII_Code |
4MT4VIE29P |
|
Has_Free_Acid_Or_Base_Form | ||
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
label |
Atazanavir Sulfate |
|
Legacy Concept Name |
Atazanavir |
|
Preferred_Name |
Atazanavir Sulfate |
|
prefixIRI |
NCIT:C28835 |
|
prefLabel |
Atazanavir Sulfate |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C1176383 |
|
subClassOf |